Delivery Order SPE2DB22D2214-SPE2DB23FS5QA
Award Date 7/24/23
Potential Completion Date 7/25/23
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $474.60 delivery order to Amerisourcebergen Drug Corporation for 4561888702 FEBUXOSTAT 80 MG TABLET 30S. The firm fixed price order is being fulfilled under an existing contract vehicle by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania. The order is for a one-day period of performance extending from August 21, 2023 to August 22, 2023 to supply the pharmaceutical product febuxostat to support the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $1,609.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561783093 FEBUXOSTAT 40 MG TABLET 30S. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the requested Febuxostat tablets to the place of performance in Conshohocken, Pennsylvania between August 11-14, 2023. The Defense Logistics Agency is the funding agency for this delivery order placed against an unspecified...
- This delivery order for $2,186.55, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, is for the purchase of 30 tablets of Febuxostat 40 mg each. The place of performance is in Conshohocken, Pennsylvania, and all items are to be delivered by October 20, 2023. No set-aside provision was specified. As the Defense Logistics Agency is responsible for worldwide logistics support of the U.S. Department of Defense, this order is likely intended to supply military treatment...
- The Defense Logistics Agency awarded a delivery order valued at $6,258.05 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by November 14, 2025. The order was placed to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,141.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Febuxostat 40 mg tablets (30-count units). The contract represents a non-set-aside, competitively awarded delivery order with a completion date of December 18, 2025, and performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Troop Support Medical awarded a $1,347.82 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561466171 FEBUXOSTAT 40 MG TABLET 30S. The place of performance is Conshohocken, Pennsylvania. The firm fixed price order has a period of performance from July 11, 2023 through July 12, 2023 to supply the requested pharmaceutical products. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the...
- The Defense Logistics Agency Troop Support Medical awarded a $13,513.91 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of 40 mg febuxostat. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. This delivery order was awarded under an indefinite-delivery/indefinite-quantity contract vehicle but details of the underlying contract were not provided. No set-aside designation or subcontractors were indicated. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,382.30 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units) on October 30, 2025, with completion targeted for October 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $913.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4562088348 FEBUXOSTAT 40 MG TABLETS (30 count). The prime contractor, Amerisourcebergen Drug Corporation, will deliver the pharmaceutical products from its facility located in Conshohocken, Pennsylvania. Funding is provided by the Defense Logistics Agency to support its medical supply needs. The order period of performance spans from September 7-8, 2023. No...
- The Defense Logistics Agency awarded a $1,423.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561837303 FEBUXOSTAT 40 MG TABLETS (30 count). The prime contractor, Amerisourcebergen Drug Corporation, will deliver the requested pharmaceutical product from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency is the funding agency for this delivery order placed under an existing pharmaceutical supply contract vehicle. No major...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB23FS5QADelivery Order
The Defense Logistics Agency awarded a $1,073.67 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561585141 FEBUXOSTAT 40 MG TABLET 30S. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 24-25, 2023. The Defense Logistics Agency supports military readiness by procuring, managing and distributing medical supplies and pharmaceuticals to military treatment facilities worldwide. No set aside designation or subcontractors were indicated. This delivery order under an indefinite-delivery/indefinite-quantity contract will provide febuxostat tablets, used to treat hyperuricemia and gout, to fulfill DLA requirements over the short performance period.
Generated 12/17/23, 1:32 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/24/23 |